OAS1 and OAS3 Negatively Regulate the Expression of Chemokines and Interferon-responsive Genes in Human Macrophages

Overview

Journal BMB Rep

Specialties Biochemistry
Molecular Biology

Date 2018 Aug 7

PMID 30078389

Citations 20

Authors

Wook-Bin Lee

Won Young Choi

Dong-Hyun Lee

Hyeran Shim

Jeongsil Kim-Ha

Young-Joon Kim

Affiliations

Soon will be listed here.

Abstract

Upon viral infection, the 2', 5'-oligoadenylate synthetase (OAS)-ribonuclease L (RNaseL) system works to cleave viral RNA, thereby blocking viral replication. However, it is unclear whether OAS proteins have a role in regulating gene expression. Here, we show that OAS1 and OAS3 act as negative regulators of the expression of chemokines and interferonresponsive genes in human macrophages. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein-9 nuclease (Cas9) technology was used to engineer human myeloid cell lines in which the OAS1 or OAS3 gene was deleted. Neither OAS1 nor OAS3 was exclusively responsible for the degradation of rRNA in macrophages stimulated with poly(I:C), a synthetic surrogate for viral double-stranded (ds)RNA. An mRNA sequencing analysis revealed that genes related to type I interferon signaling and chemokine activity were increased in OAS1-/- and OAS3-/- macrophages treated with intracellular poly(I:C). Indeed, retinoic-acid-inducible gene (RIG)-I- and interferon-induced helicase C domain-containing protein (IFIH1 or MDA5)-mediated induction of chemokines and interferon-stimulated genes was regulated by OAS3, but Toll-like receptor 3 (TLR3)- and TLR4-mediated induction of those genes was modulated by OAS1 in macrophages. However, stimulation of these cells with type I interferons had no effect on OAS1- or OAS3-mediated chemokine secretion. These data suggest that OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages. [BMB Reports 2019; 52(2): 133-138].

Citing Articles

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering.

Yamamura R, Kinoshita M, Yasumizu Y, Yata T, Kihara K, Motooka D Front Immunol. 2025; 16:1508977.

PMID: 39963140 PMC: 11830620. DOI: 10.3389/fimmu.2025.1508977.

Critical role of Oas1g and STAT1 pathways in neuroinflammation: insights for Alzheimer's disease therapeutics.

Xie Z, Li L, Hou W, Fan Z, Zeng L, He L J Transl Med. 2025; 23(1):182.

PMID: 39953505 PMC: 11829366. DOI: 10.1186/s12967-025-06112-2.

Interleukin-1 signaling and CD4 T cells control B cell recruitment to the lungs in chronic beryllium disease.

Gaballa J, Valdez C, Mack D, Minhajuddin F, Raza M, Mohammad T Front Immunol. 2025; 16:1479348.

PMID: 39935485 PMC: 11810750. DOI: 10.3389/fimmu.2025.1479348.

Low protein diet protects the liver from Salmonella Typhimurium-mediated injury by modulating the mTOR/autophagy axis in macrophages.

Wojtowicz E, Hampton K, Moreno-Gonzalez M, Utting C, Lan Y, Ruiz P Commun Biol. 2024; 7(1):1219.

PMID: 39349819 PMC: 11444042. DOI: 10.1038/s42003-024-06932-w.

Discovering common pathogenetic processes between COVID-19 and tuberculosis by bioinformatics and system biology approach.

Huang T, He J, Zhou X, Pan H, He F, Du A Front Cell Infect Microbiol. 2024; 13:1280223.

PMID: 38162574 PMC: 10757339. DOI: 10.3389/fcimb.2023.1280223.

References

Justesen J, Hartmann R, KJELDGAARD N . Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci. 2000; 57(11):1593-612. PMC: 11146851. DOI: 10.1007/pl00000644. View

Behera A, Kumar M, Lockey R, Mohapatra S . 2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem. 2002; 277(28):25601-8. DOI: 10.1074/jbc.M200211200. View

Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman D, Ishii K . Transcriptional regulation of the human TLR9 gene. J Immunol. 2004; 173(4):2552-61. DOI: 10.4049/jimmunol.173.4.2552. View

Samuel M, Whitby K, Keller B, Marri A, Barchet W, Williams B . PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol. 2006; 80(14):7009-19. PMC: 1489062. DOI: 10.1128/JVI.00489-06. View

Mantovani A, Bonecchi R, Locati M . Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006; 6(12):907-18. DOI: 10.1038/nri1964. View

Hovanessian A, Justesen J . The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie. 2007; 89(6-7):779-88. DOI: 10.1016/j.biochi.2007.02.003. View

Takeuchi O, Akira S . MDA5/RIG-I and virus recognition. Curr Opin Immunol. 2008; 20(1):17-22. DOI: 10.1016/j.coi.2008.01.002. View

Yoneyama M, Fujita T . RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev. 2009; 227(1):54-65. DOI: 10.1111/j.1600-065X.2008.00727.x. View

Lim J, Lisco A, McDermott D, Huynh L, Ward J, Johnson B . Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009; 5(2):e1000321. PMC: 2642680. DOI: 10.1371/journal.ppat.1000321. View

10.

Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell. 2010; 140(6):805-20. DOI: 10.1016/j.cell.2010.01.022. View

11.

Kristiansen H, Scherer C, McVean M, Iadonato S, Vends S, Thavachelvam K . Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J Virol. 2010; 84(22):11898-904. PMC: 2977878. DOI: 10.1128/JVI.01003-10. View

12.

Kristiansen H, Gad H, Eskildsen-Larsen S, Despres P, Hartmann R . The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. 2010; 31(1):41-7. DOI: 10.1089/jir.2010.0107. View

13.

Kawai T, Akira S . Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011; 34(5):637-50. DOI: 10.1016/j.immuni.2011.05.006. View

14.

Li S, Wang L, Berman M, Kong Y, Dorf M . Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011; 35(3):426-40. PMC: 3253658. DOI: 10.1016/j.immuni.2011.06.014. View

15.

Donovan J, Dufner M, Korennykh A . Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1. Proc Natl Acad Sci U S A. 2013; 110(5):1652-7. PMC: 3562804. DOI: 10.1073/pnas.1218528110. View

16.

Alagarasu K, Honap T, Damle I, Mulay A, Shah P, Cecilia D . Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. Infect Genet Evol. 2013; 14:390-5. DOI: 10.1016/j.meegid.2012.12.021. View

17.

Zhao L, Birdwell L, Wu A, Elliott R, Rose K, Phillips J . Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus. J Virol. 2013; 87(15):8408-18. PMC: 3719824. DOI: 10.1128/JVI.00769-13. View

18.

Kim T, Lee H . Innate immune recognition of respiratory syncytial virus infection. BMB Rep. 2014; 47(4):184-91. PMC: 4163887. DOI: 10.5483/bmbrep.2014.47.4.050. View

19.

Banerjee S, Chakrabarti A, Jha B, Weiss S, Silverman R . Cell-type-specific effects of RNase L on viral induction of beta interferon. mBio. 2014; 5(2):e00856-14. PMC: 3940032. DOI: 10.1128/mBio.00856-14. View

20.

Cai Y, Chen Q, Zhou W, Chu C, Ji W, Ding Y . Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease. Int J Immunogenet. 2014; 41(5):384-92. DOI: 10.1111/iji.12134. View